Allied Market Research
Health Economics And Outcomes Research (heor) Services Market

Health Economics And Outcomes Research (Heor) Services Market

Size, Share, Competitive Landscape and Trend Analysis Report by Service Type (Real World Data Analysis and Information Systems, Market Access Solutions and Reimbursement, Others), by Service provider (Contract research organizations (CROs), Consultancies), by End user (Healthcare payers, Pharma and Biotech companies, Others): Global Report opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A08109
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Healthcare decision makers all over often face the situation wherein they need to select therapeutic interventions from multiple treatment options, including biopharmaceuticals, medical devices and healthcare services considering the benefits and costs of these products, which can range dramatically depending on type of treatment and the benefits can be economic, clinical or both and may also include hard to measure benefits, the patient experiences directly. It is the application of principles of economics, in healthcare to prioritize the needs of the public based on cost effectiveness of treatment. Health economics and outcomes research (HEOR) aids healthcare decision makers including clinicians, governments, payers, health ministries, patients to adequately compare and choose among the best possible option for treatment. HEOR can be any function within pharmaceutical, biologics, healthcare and life science companies, to whom the responsibility of assessing the value of new drugs for reimbursement agencies and local health care payers is assigned. Health economics (HOER) uses clinical and economic evidence to determine the value of drugs, and looks at the factors that can affect this value, which are majorly the current healthcare climate and the patient.


COVID – 19 scenario analysis:  

  • Economies across the globe are struggling amidst COVID – 19 pandemic, as the governments have imposed travel restrictions and lockdowns
  • Many of the industrial sectors are struggling as they’re closed
  • However, Health Economics & Outcomes Research (HEOR) can be of a great help in times like COVID – 19 
  • Pharmaceutical  and biotech majors, across the globe are investing, pouring funds for R&D activities and are engaged in search for innovating a vaccine or a therapeutic treatment in order to prevent, resist or cure the people suffering from novel coronavirus
  • HEOR can play a big role in this scenario, as it can help the pharmaceutical and biologics firms to evaluate their spending on the upcoming product or treatment
  • It would also play a lead role in helping the government officials is decision making related to which treatment to go for, considering effectiveness and affordability the prime factors 

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Burdened by limited resources, the decision makers face the dilemma of balancing the healthcare needs of a few patients with the healthcare needs of the larger society. At a higher level, a similar dilemma is faced by a hospital, government or pharma company, when an introduction of a new drug. The doctors, government is interested in knowing significance of the drug to the patient also considering affordability. HEOR comes into picture here and helps the decision makers optimize the resources in health and make a better decision. Factors like increasing prevalence of chronic diseases, growing burden on the healthcare, pharma and biotech industries are heavily funding R&D activities for development of new drugs, therapeutic procedures and clinical trials for the better health, increasing spending on drugs on payer’s healthcare budget are major hurdle in several regions. Henceforth, focus of health economics and outcomes research service providers on providing optimal health outcomes for patients from an affordable perspective will increase its demand over the period of time, thereby facilitating the overall industry growth. However, lack of trained professionals in developing and underdeveloped countries to carry on such type of research is the major factor limiting the health economics and outcomes research (HOER) services market growth.

Booming pharmaceutical industry, upsurge of new drugs and increasing clinical trials to fuel the market growth

The global pharmaceutical market from $ 100 billion in 2017, is expected to reach $ 1.5trillion by 2023. Tremendous growth in the pharma industry has led to immense competition among pharma companies and as a result many drugs belonging to the same class have been made available to the prescriber. Different brands of the same drug are often at the offering end of the prescriber. This brings in confusion as to which brand should be chosen. According to the National Institute of Health, in 2018, the U.S. government invested $ 13,870 million in clinical research and $ 5,207 million in clinical trials and related activities. Along with new drugs development, number of clinical trials is also conducted is also increasing drastically which is essential to support the drug developments. 

HEOR plays a vital role for the pharmaceutical industry by providing inputs for fixing the price of a new drug, and for re-fixing the price of an existing drug in the context of another similar drug of a rival pharmaceutical industry entering the market. Hence the market growth of health economics and outcome research would take place with growing pharma sector.

Pharmaceutical companies preferring CROs for performing HEOR on their behalf

Contract research organizations involved in healthcare sector, generally hold expertise in a wide range of topics related to the industry and provide assistance to biotechnology, medical device and pharmaceutical companies in the form of research services outsourced on a contract basis. Several companies including IQVIA, ICON and Covance among others are involved in offering contract-based research services in healthcare. Rising demand for secured services including clinical and preclinical testing as well as expertise in regulatory affairs will enhance the overall market growth.  Use of healthcare IT and analytic tools allow these CROs to align across diverse platforms which will further increase the need for HEOR services in payer decision making, thus proving beneficial for the health economics and outcomes research (HOER) services market growth. Recently, ICON introduced advanced virtual patient engagement platform to support enrollment in clinical trials and get reviews. It provides patients with connectivity and study specific data.

Key benefits of the report:

  • This study presents the analytical depiction of the global health economics and outcomes research (HOER) services industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global health economics and outcomes research (HOER) services market share.
  • The current market is quantitatively analysed to highlight the global health economics and outcomes research (HOER) services market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the health economics and outcomes research (HOER) services market.
  • The report provides a detailed global health economics and outcomes research (HOER) services market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Health Economics and Outcomes Research (HOER) Services Market research report:

  • Who are the leading market players active in the health economics and outcomes research (HOER) services market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

Health Economics And Outcomes Research (Heor) Services Market Report Highlights

Aspects Details
By Service Type
  • Real World Data Analysis and Information Systems
  • Market Access Solutions and Reimbursement
  • Others
By Service Provider
  • Contract research organizations (CROs)
  • Consultancies
By End User
  • Healthcare payers
  • Pharma and Biotech companies
  • Others
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
Related Tags

Purchase Full Report of
Health Economics And Outcomes Research (heor) Services Market

Start reading.
This Report and over 71,213+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
*Terms and Conditions Apply

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers